Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
78.42
-0.11 (-0.14%)
At close: Mar 26, 2026, 4:00 PM EDT
79.20
+0.78 (0.99%)
After-hours: Mar 26, 2026, 4:53 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $5.45 billion as of March 26, 2026. Its market cap has increased by 132.95% in one year.
Market Cap
5.45B
Enterprise Value
4.66B
1-Year Change
132.95%
Ranking
Category
Stock Price
$78.42
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $5.45B, an increase of 573.65%. That is a compound annual growth rate of 102.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 5.80B | 13.84% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 5.69B |
| Cogent Biosciences | 5.65B |
| PTC Therapeutics | 5.36B |
| CG Oncology | 5.34B |
| Caris Life Sciences | 5.30B |
| Mirum Pharmaceuticals | 5.28B |
| Xenon Pharmaceuticals | 5.09B |
| Immunovant | 4.89B |